Targeting Cancer Drug Resistance
Conference - Chicago, Illinois, United States
Targeting Cancer Drug Resistance is the world's only commercially focused meeting that specifically addresses your priorities as a drug developer in understanding and overcoming mechanisms of cancer drug resistance.
The agenda has been carefully designed by experts from the likes of GSK, Bristol-Myers Squibb, Gilead and MD Anderson, Harvard Medical School and Massachusetts General Hospital. These industry leaders are focused on overcoming the key barriers currently preventing better drugs for cancer patients and they are coming to our meeting to share their knowledge and experience with you. Leave this meeting armed with information to nurture the therapies, that you are investing in, and delay or overcome cancer drug resistance.
The meeting will take an in-depth look at:
Biology of the tumor and mechanisms of resistance. Learn how you can utilize the most current knowledge to develop therapies that are better at targeting drug resistance.
Combination therapies. Discover how to test for combination quickly and effectively. Be part of industry-leading discussions about drug administration approaches that will optimize patient safety and drug efficacy.
Cancer stem cells. Explore their role in resistance mechanisms, how you can target them in the clinic and how this can reduce the chance of patient relapse.
Resistance Diagnosis. Increase your accuracy and efficiency to maximise drug efficacy and minimise toxicity and waste.
(Courtesy of End-Running Cancer Resistance to Targeted Therapies genengnews.com)
Targeting Cancer Drug Resistance
Tue, May 28, 2013 - Fri, May 31, 2013
Hilton Chicago/Magnificent Mile Suites
198 E. Delaware Place, Chicago, Illinois 60611-1719, USA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.